Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome

Fertility and Sterility

Volumn 67, Issue 4, 1997, Pages 724-727

  Benadiva, Claudio A ^a,b   Moomjy, Maureen ^a   Davis, Owen ^a   Liu, Hung Ching ^a   Kligman, Isaac ^a   Rosenwaks, Zev ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NEW BRITAIN GENERAL HOSPITAL   (United States)

Author keywords

cryopreservation; In vitro fertilization; ovarian hyperstimulation syndrome

Indexed keywords

CHORIONIC GONADOTROPIN; GONADOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CRYOPRESERVATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG WITHDRAWAL; EMBRYO TRANSFER; FERTILIZATION IN VITRO; HIGH RISK PATIENT; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; OVARY DISEASE; PRIORITY JOURNAL; SPONTANEOUS ABORTION; THAWING;

EID: 0342437505     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)81373-8     Document Type: Article

References (13)

1. Schenker JG. Prevention and treatment of ovarian hyperstimulation. Hum Reprod 1993;8:653-9.
2. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992;58:249-61.
3. Belaisch-Allart J, Belaisch J, Hazout A, Testart J, Frydman R. Selective oocyte retrieval: a new approach to ovarian hyperstimulation. Fertil Steril 1988;50:654-6.
4. Aboulghar MA, Mansour RT, Serour GI, Elattar I, Amin Y. Follicular aspiration does not protect against the development of ovarian hyperstimulation syndrome. J Assist Reprod Genet 1992;9:238-43.
5. Frederick JL, Ord T, Kettel LM, Stone SC, Balmaceda JP, Asch RH. Successful pregnancy outcome after cryopreservation of all fresh embryos with subsequent transfer into an unstimulated cycle. Fertil Steril 1995;64:987-90.
6. Amso NN, Ahuja KK, Morris N, Shaw RW. The management of predicted ovarian hyperstimulation involving gonadotropin-releasing hormone analog with elective cryopreservation of all pre-embryos. Fertil Steril 1990;53:1087-90.
7. Shaker AG, Zosmer A, Dean N, Bekir JS, Jacobs HS, Tan S-L. Comparison of intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos for subsequent transfer in prevention of ovarian hyperstimulation syndrome. Fertil Steril 1996;65:992-6.
8. Urman B, Pride SM, Ho Yuen B. Management of overstimulated gonadotropin cycles with a controlled drift period. Hum Reprod 1992; 7:213-7.
9. Ben-Nun I, Shulman A, Ghetler Y, Shilon M, Kaneti H, Beyth Y. The significance of 17β-estradiol levels in highly responding women during ovulation induction in IVF treatment: its impact and prognostic value with respect to oocyte maturation and treatment outcome. J Assist Reprod Genet 1993; 10:213-5.
10. Sher G, Salem R, Feinman M, Dodge S, Zouves C, Knutzen V. Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer. Obstet Gynecol 1993;81:1009-11.
11. Sher G, Zouves C, Feinman M, Maassarani G. "Prolonged coasting": an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Hum Reprod 1995; 10:3107-9.
12. Benadiva CA, Kligman I, Rosenwaks Z. Assisted reproductive technology versus tubal surgery. In: Sanfilippo JS, Levine RL, editors. Operative gynecologic endoscopy. New York: Springer-Verlag, 1996:278-305.
13. Benadiva CA, Ben-Rafael Z, Blasco L, Tureck R, Mastroianni L Jr., Flickinger GL. Ovarian response to human menopausal gonadotropin following suppression with oral contraceptives. Fertil Steril 1988;50:516-8.